Nifty
Sensex
:
:
23465.60
76992.77
66.70 (0.29%)
181.87 (0.24%)

Pharmaceuticals & Drugs - Domestic

Rating :
57/99

BSE: 500674 | NSE: SANOFI

6838.70
14-Jun-2024
  • Open
  • High
  • Low
  • Previous Close
  •  6838.70
  •  6838.70
  •  6633.00
  •  6513.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  41175
  •  2805.46
  •  10524.95
  •  5892.80

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 15,749.95
  • 28.68
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 15,343.45
  • 2.44%
  • 14.54

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 60.40%
  • 0.89%
  • 7.97%
  • FII
  • DII
  • Others
  • 6.11%
  • 22.84%
  • 1.79%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.73
  • -1.47
  • -1.20

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.09
  • 3.83
  • 1.04

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.63
  • 7.81
  • -13.88

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 34.16
  • 32.41
  • 23.06

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.88
  • 10.88
  • 12.54

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.56
  • 19.45
  • 18.64

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
732.40
0.00
0
693.90
0.00
0
714.60
0.00
0
706.10
0.00
0
Expenses
513.50
0.00
0
506.50
0.00
0
506.40
0.00
0
527.90
0.00
0
EBITDA
218.90
0.00
0
187.40
0.00
0
208.20
0.00
0
178.20
0.00
0
EBIDTM
29.89%
0.00%
27.01%
0.00%
29.14%
0.00%
25.24%
0.00%
Other Income
6.50
0.00
0
12.00
0.00
0
11.80
0.00
0
15.70
0.00
0
Interest
0.30
0.00
0
0.40
0.00
0
0.30
0.00
0
0.70
0.00
0
Depreciation
10.00
0.00
0
10.20
0.00
0
9.90
0.00
0
9.80
0.00
0
PBT
188.40
0.00
0
188.80
0.00
0
209.80
0.00
0
183.40
0.00
0
Tax
51.80
0.00
0
51.10
0.00
0
57.90
0.00
0
60.50
0.00
0
PAT
136.60
0.00
0
137.70
0.00
0
151.90
0.00
0
122.90
0.00
0
PATM
18.65%
0.00%
19.84%
0.00%
21.26%
0.00%
17.41%
0.00%
EPS
59.39
0.00
0
59.87
0.00
0
66.04
0.00
0
53.43
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Dec 23
Net Sales
-
2,851.10
Net Sales Growth
-
 
Cost Of Goods Sold
-
1,201.00
Gross Profit
-
1,650.10
GP Margin
-
57.88%
Total Expenditure
-
2,048.60
Power & Fuel Cost
-
14.60
% Of Sales
-
0.51%
Employee Cost
-
370.60
% Of Sales
-
13.00%
Manufacturing Exp.
-
74.00
% Of Sales
-
2.60%
General & Admin Exp.
-
176.90
% Of Sales
-
6.20%
Selling & Distn. Exp.
-
166.80
% Of Sales
-
5.85%
Miscellaneous Exp.
-
44.70
% Of Sales
-
1.57%
EBITDA
-
802.50
EBITDA Margin
-
28.15%
Other Income
-
66.50
Interest
-
1.70
Depreciation
-
39.60
PBT
-
827.70
Tax
-
242.60
Tax Rate
-
28.69%
PAT
-
602.90
PAT before Minority Interest
-
602.90
Minority Interest
-
0.00
PAT Margin
-
21.15%
PAT Growth
-
 
EPS
-
262.13

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 23
Shareholder's Funds
1,015.20
Share Capital
23.00
Total Reserves
923.90
Non-Current Liabilities
1,152.90
Secured Loans
0.00
Unsecured Loans
0.00
Long Term Provisions
1,135.30
Current Liabilities
2,534.70
Trade Payables
291.50
Other Current Liabilities
31.40
Short Term Borrowings
0.00
Short Term Provisions
2,211.80
Total Liabilities
4,702.80
Net Block
314.90
Gross Block
551.90
Accumulated Depreciation
237.00
Non Current Assets
1,571.40
Capital Work in Progress
15.90
Non Current Investment
0.00
Long Term Loans & Adv.
1,233.20
Other Non Current Assets
7.40
Current Assets
3,131.40
Current Investments
0.00
Inventories
663.80
Sundry Debtors
131.70
Cash & Bank
406.50
Other Current Assets
1,929.40
Short Term Loans & Adv.
1,914.60
Net Current Assets
596.70
Total Assets
4,702.80

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 23
Cash From Operating Activity
230.40
PBT
845.50
Adjustment
-24.80
Changes in Working Capital
-349.00
Cash after chg. in Working capital
471.70
Interest Paid
0.00
Tax Paid
-241.30
Other Direct Exp. Paid
0.00
Extra & Other Items
0.00
Cash From Investing Activity
37.50
Net Fixed Assets
Net Investments
Others
Cash from Financing Activity
-878.30
Net Cash Inflow / Outflow
-610.40
Opening Cash & Equivalents
1,004.90
Closing Cash & Equivalent
394.50

Financial Ratios

Standalone /

Consolidated
Description
Dec 23
Book Value (Rs.)
411.70
ROA
22.71%
ROE
87.18%
ROCE
115.15%
Fixed Asset Turnover
6.97
Receivable days
13.83
Inventory Days
47.71
Payable days
50.43
Cash Conversion Cycle
11.11
Total Debt/Equity
0.00
Interest Cover
498.35

News Update:


  • Sanofi India - Quarterly Results
    13th May 2024, 19:03 PM

    Read More
  • Sanofi India enters into partnership with Cipla
    27th Mar 2024, 11:42 AM

    As a part of this partnership, Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.